CD4 and bacterial infectious disease: HIV-1 seropositive specimens were obtained from patients receiving Cotrimoxazole prophylaxis, which is routinely administered to patients with low CD4+ T-lymphocyte counts in order to prevent potentially fatal bacterial infections.